Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: THE EMMES COMPANY, LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-08-15 to 2026-03-31
Current total value of award: $525738
Description: RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF INJECTABLE NALTREXONE AND MONTHLY INJECTABLE BUPRENORPHINE FOR COCAINE USE DISORDER (CTN-0109). AUGUST 15, 2024 TO MARCH 31, 2026. N01DA-22-2253. TASK ORDER NO. 75N95024F00006 (TO22).